Co-Target(s) Information
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T78356 | Target Info | |||
| Target Name | Thromboxane-A synthase (TBXAS1) | ||||
| Synonyms |
Thromboxane A2 synthase; TXS; TXA synthase; Cytochrome P450 5A1; CYP5A1; CYP5
Click to Show/Hide
|
||||
| Target Type | Clinical trial Target | ||||
| Gene Name | TBXAS1 | ||||
| Biochemical Class | Intramolecular oxidoreductase | ||||
| UniProt ID | |||||
| Co-Targets of This Target | Top | |||||
|---|---|---|---|---|---|---|
| Co-Target Name | Nicotinate phosphoribosyltransferase (NAPRT) | Co-Target | ||||
| UniProt ID | PNCB_HUMAN | |||||
| Gene Name | NAPRT | |||||
| Synonyms |
NAPRTase; FHA-HIT-interacting protein; Nicotinate phosphoribosyltransferase domain-containing protein 1
Click to Show/Hide
|
|||||
| Representative Drug(s) | PYRIDINE | Drug Info | Ki = 0.78 nM | [1] | ||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | WHO patent application no. 2017162840A1, SENSITIZATION OF CANCER CELLS TO NAMPT INHIBITORS BY NICOTINIC ACID PHOSPHORIBOSYLTRANSFERASE NEUTRALIZATION. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.